17-8289059-G-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2

The NM_016492.5(RANGRF):​c.181G>T​(p.Glu61*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00449 in 1,613,690 control chromosomes in the GnomAD database, including 29 homozygotes. Variant has been reported in ClinVar as Likely benign (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0036 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 27 hom. )

Consequence

RANGRF
NM_016492.5 stop_gained

Scores

1
4
2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 2.19

Publications

25 publications found
Variant links:
Genes affected
RANGRF (HGNC:17679): (RAN guanine nucleotide release factor) This gene encodes a protein that has been shown to function as a guanine nucleotide release factor in mouse and to regulate the expression and function of the Nav1.5 cardiac sodium channel in human. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
SLC25A35 (HGNC:31921): (solute carrier family 25 member 35) SLC25A35 belongs to the SLC25 family of mitochondrial carrier proteins (Haitina et al., 2006 [PubMed 16949250]).[supplied by OMIM, Mar 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP6
Variant 17-8289059-G-T is Benign according to our data. Variant chr17-8289059-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 190845.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 551 Unknown,AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RANGRFNM_016492.5 linkc.181G>T p.Glu61* stop_gained Exon 2 of 5 ENST00000226105.11 NP_057576.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RANGRFENST00000226105.11 linkc.181G>T p.Glu61* stop_gained Exon 2 of 5 1 NM_016492.5 ENSP00000226105.6

Frequencies

GnomAD3 genomes
AF:
0.00362
AC:
551
AN:
152238
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000844
Gnomad AMI
AF:
0.0110
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00988
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00534
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00400
AC:
996
AN:
248904
AF XY:
0.00390
show subpopulations
Gnomad AFR exome
AF:
0.000750
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.000200
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0109
Gnomad NFE exome
AF:
0.00562
Gnomad OTH exome
AF:
0.00541
GnomAD4 exome
AF:
0.00458
AC:
6693
AN:
1461334
Hom.:
27
Cov.:
32
AF XY:
0.00452
AC XY:
3284
AN XY:
726980
show subpopulations
African (AFR)
AF:
0.000747
AC:
25
AN:
33476
American (AMR)
AF:
0.00112
AC:
50
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000230
AC:
6
AN:
26130
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.00189
AC:
163
AN:
86256
European-Finnish (FIN)
AF:
0.0104
AC:
552
AN:
52972
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.00508
AC:
5650
AN:
1111934
Other (OTH)
AF:
0.00399
AC:
241
AN:
60378
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
391
782
1174
1565
1956
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
186
372
558
744
930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00362
AC:
551
AN:
152356
Hom.:
2
Cov.:
32
AF XY:
0.00353
AC XY:
263
AN XY:
74498
show subpopulations
African (AFR)
AF:
0.000842
AC:
35
AN:
41590
American (AMR)
AF:
0.00105
AC:
16
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.00988
AC:
105
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00534
AC:
363
AN:
68028
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
33
65
98
130
163
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00432
Hom.:
2
Bravo
AF:
0.00298
TwinsUK
AF:
0.00458
AC:
17
ALSPAC
AF:
0.00389
AC:
15
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00535
AC:
46
ExAC
AF:
0.00395
AC:
479
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00551
EpiControl
AF:
0.00486

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
May 10, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Sep 16, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: RANGRF c.181G>T (p.Glu61X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, however current evidence is not sufficient to establish loss of function as a mechanism for disease. The variant allele was found at a frequency of 0.0045 in 1606716 control chromosomes in the gnomAD database (v4.1 dataset). , including 29 homozygotes. The observed variant frequency is approximately 700-fold of the estimated maximal expected allele frequency for a pathogenic variant in RANGRF causing Arrhythmia phenotype (6.3e-06). Although the variant was proposed to be related to various phenotypes in the literature, a recent study performing exhaustive genetic interpretation of reported variants in minor genes (potentially) associated with Brugada syndrome, classified the variant as benign (Campuzano_2019). The following publication have been ascertained in the context of this evaluation (PMID: 30821013). ClinVar contains an entry for this variant (Variation ID: 190845). Based on the evidence outlined above, the variant was classified as benign. -

not provided Benign:2
Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

RANGRF: BS2; SLC25A35: BS2 -

-
Molecular Diagnostic Laboratory for Inherited Cardiovascular Disease, Montreal Heart Institute
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RANGRF-related disorder Benign:1
Nov 20, 2020
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Cardiac arrhythmia Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Uncertain
0.047
T
BayesDel_noAF
Pathogenic
0.30
CADD
Pathogenic
37
DANN
Uncertain
0.99
Eigen
Uncertain
0.40
Eigen_PC
Benign
0.15
FATHMM_MKL
Uncertain
0.83
D
PhyloP100
2.2
Vest4
0.27
GERP RS
4.4
PromoterAI
0.092
Neutral
Mutation Taster
=68/132
disease causing (fs/PTC)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.22
Details are displayed if max score is > 0.2
DS_DG_spliceai
0.22
Position offset: -10

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs140704891; hg19: chr17-8192377; COSMIC: COSV56840201; COSMIC: COSV56840201; API